1 |
Du R, Cheng X, Ji J, Lu Y, Xie Y, Wang W, Xu Y, Zhang Y. Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin. Sci Rep 2023;13:4463. [PMID: 36932163 DOI: 10.1038/s41598-023-31712-7] [Reference Citation Analysis]
|
2 |
Zhang JH, Chen JH, Guo B, Fang Y, Xu ZY, Zhan L, Cao YX. Recent insights into non-coding RNAs in primary ovarian insufficiency: focus on mechanisms and treatments. J Clin Endocrinol Metab 2023:dgad070. [PMID: 36735959 DOI: 10.1210/clinem/dgad070] [Reference Citation Analysis]
|
3 |
Zafardoust S, Kazemnejad S, Darzi M, Fathi-Kazerooni M, Saffarian Z, Khalili N, Edalatkhah H, Mirzadegan E, Khorasani S. Intraovarian Administration of Autologous Menstrual Blood Derived-Mesenchymal Stromal Cells in Women with Premature Ovarian Failure. Arch Med Res 2023;54:135-44. [PMID: 36702667 DOI: 10.1016/j.arcmed.2022.12.015] [Reference Citation Analysis]
|
4 |
Wang R, Yang X. FTO attenuates the cytotoxicity of cisplatin on KGN cells by regulating the Hippo/YAP1 signaling pathway Short title:FTO disrupts the Hippo/YAP1 signaling pathway.. [DOI: 10.21203/rs.3.rs-2193407/v1] [Reference Citation Analysis]
|
5 |
Wang R, Wang L, Wang L, Cui Z, Cheng F, Wang W, Yang X. FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy. Front Endocrinol 2022;13:890623. [DOI: 10.3389/fendo.2022.890623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|